封面
市场调查报告书
商品编码
1708904

凝结巴提拉菌市场:依应用与地区

Bacillus Coagulans Market, by Application (Bakery products, Confectionery, Dairy products, Beverages, Functional Food, and Animal Feed) And by Region (North America, Latin America, Asia Pacific, Europe, and Middle East & Africa)

出版日期: | 出版商: Coherent Market Insights | 英文 100 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计 2025 年全球凝结芽孢桿菌市值为 1.271 亿美元,到 2032 年将达到 2.25 亿美元,预计 2025 年至 2032 年的年复合成长率(CAGR)为 8.5%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 1.271亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 8.50% 2032年价值预测 2.25亿美元
数字。 2025年凝结芽孢桿菌各地区市场占有率(%)
凝结芽孢桿菌市场-IMG1

凝结芽孢桿菌是一种产芽孢细菌,主要用于益生菌特性。众所周知,食用这种细菌可以改善肠道菌丛并延缓胃病和消化系统疾病的发生。这种细菌可用于烘焙食品、糖果零食、乳製品、食品和饮料、机能性食品和动物饲料等产品。凝结芽孢桿菌,以前称为产孢乳桿菌,通常称为乳酸菌,是一种革兰氏阳性、产芽孢细菌,用作益生菌。凝结芽孢桿菌无致病性,对人类食用有益。它用于治疗多种疾病,包括腹泻、便秘、消化器官系统问题、乳糖不耐症和增强免疫力。

市场动态

由于凝结巴氏杀菌素在治疗皮肤问题和痤疮方面具有巨大功效,其市场在化妆品行业的需求日益增长。化妆品供应商正在推出含有凝结芽孢桿菌的新配方,以发挥抗衰老功效。

益生菌产业的重大进步有望推动全球凝结芽孢桿菌市场的成长。肥胖症和非传染性疾病盛行率的上升是推动市场成长的关键因素。亚太地区新兴经济体消费者对健康和疾病的意识不断提高,推动了对益生菌、补充剂和机能性食品等保健产品的需求。此外,业界对新型益生菌产品研发的投入也带来了一系列新产品的推出,并为製造商开拓了一系列新市场。然而,政府对益生菌批准的严格规定可能会阻碍凝结芽孢桿菌市场的成长。该公司努力将益生菌以各种有吸引力的配方(如棒、优格、咀嚼片等)的形式呈现,预计将吸引人们购买益生菌和益生元产品,推动全球凝结芽孢桿菌市场的成长。

本研究的主要特点

  • 本报告对全球凝结芽孢桿菌市场进行了详细分析,并提供了预测期(2025-2032)的市场规模和年复合成长率(CAGR),假设 2024 年为基准年。
  • 它还揭示了各个领域的潜在商机,并解释了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、区域前景以及主要企业采用的竞争策略的重要见解。
  • 它根据公司概况、业绩、产品系列、地理位置、分销策略、关键发展和策略以及未来计划等参数,介绍了全球凝结芽孢桿菌市场的主要企业概况。
  • 本报告的见解将使企业负责人和经营团队能够就未来的产品发布、技术升级、市场扩张和行销策略做出明智的决策。
  • 全球凝结芽孢桿菌市场报告涉及该行业的各个相关人员,例如投资者、供应商、凝结芽孢桿菌製造商、经销商、新进入者和金融分析师。
  • 相关人员将透过用于分析全球凝结芽孢桿菌市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 波特分析
  • 产业趋势
  • 主要亮点
  • 流行病学
  • 赎回方案
  • 监管情景
  • 产品发布和核准
  • 收购与合作场景

第四章。全球凝结芽孢桿菌市场-冠状病毒(COVID-19)大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 2020 年至 2032 年全球凝结芽孢桿菌市场(依应用)

  • 非乳製品
  • 乳製品
  • 粮食
  • 婴儿营养
  • 其他的

6. 2020 年至 2032 年全球凝结芽孢桿菌市场(依最终用户划分)

  • 化妆品製造商
  • 饮食
  • 营养补充品
  • 其他的

7. 2020 年至 2032 年全球凝结芽孢桿菌市场(按地区)

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东和非洲

第八章 竞争态势

  • 公司简介
    • Sanzyme
    • Unique Biotech Limited(UBL)
    • Zytex
    • Bioflex
    • Fengchen Group Co., Ltd
    • RAJVI Enterprise
    • Vakya life sciences
    • Sabinsa Corporation
    • Ganeden
    • UAS Laboratories
    • Mitsubishi Chemical Foods Corporation
    • Mystical Biotech Pvt. Ltd.
    • Aumgene Biosciences
    • Unique Biotech Ltd.
    • Nebraska Culture

第九章 分析师观点

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第十章参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI2155

Global Bacillus Coagulans Market is estimated to be valued at USD 127.1 Mn in 2025 and is expected to reach USD 225. Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 127.1 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 8.50% 2032 Value Projection: USD 225. Mn
Figure. Bacillus Coagulans Market Share (%), By Region 2025
Bacillus Coagulans Market - IMG1

Bacillus coagulans is a spore-forming bacterium, which is largely utilized for its probiotic nature. The bacterium on consumption is known to improve gut health and slow the onset of stomach and digestive disorders. The bacterium finds application in products such as bakery, confectionery, dairy, beverages, functional food, and animal feed. Bacillus coagulans, earlier known as lactobacillus sporogenes and generally termed as Lactic Acid Bacteria is a gram-positive, spore-forming bacterium used as a probiotic. Bacillus coagulans is non-pathogenic and beneficial for human consumption. It is used in various therapeutic treatments such as diarrhea, constipation, digestive problems, lactose intolerance, and immunity enhancement.

Market Dynamics

Bacillus coagulans market is witnessing a growing demand in the cosmetic industry, owing to the immense benefits offered in managing skin problems and acne. New formulations including bacillus coagulans are being launched by cosmetics providers for anti-aging effects.

Significant advancements in the probiotics industry is expected to drive growth of the global bacillus coagulans market. Increasing prevalence of obesity and non-communicable diseases are significant factors contributing to the market growth. Increasing consumer awareness regarding health and diseases in emerging economies of Asia Pacific has led to rising demand for healthcare products such as probiotics, supplements, and functional food. Moreover, industry spending on research & development of new probiotics products has led to the launch of various new products, which has opened up various new market avenues for manufacturers to target. However, stringent government regulations for the approval of probiotics may hinder growth of the bacillus coagulans market. The efforts by companies to represent probiotics in different attractive formulations such as bars, yogurt, and chewing tablets are expected to attract the population towards probiotics and prebiotic products, thereby driving the growth of the global bacillus coagulans market.

Key features of the study:

  • This report provides an in-depth analysis of global bacillus coagulans market, and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global bacillus coagulans market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd, Nebraska Cultures, and Syngen Biotech
  • Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future product launches, technology up gradation, market expansion, and marketing tactics
  • The global bacillus coagulans market report caters to various stakeholders in this industry including investors, suppliers, bacillus coagulans manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacillus coagulans market

Detailed Segmentation:

  • By Application:
    • Bakery Products
    • Confectionary
    • Dairy Products
    • Beverages
    • Functional Food
    • Animal Feed
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles
    • Sanzyme
    • Unique Biotech Limited (UBL)
    • Zytex
    • Bioflex
    • Fengchen Group Co., Ltd
    • RAJVI Enterprise
    • Vakya life sciences
    • Sabinsa Corporation
    • Ganeden
    • UAS Laboratories
    • Mitsubishi Chemical Foods Corporation
    • Mystical Biotech Pvt. Ltd.
    • Aumgene Biosciences
    • Unique Biotech Ltd.
    • Nebraska Culture

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Application
    • Market Snapshot, By End-Users
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Porter's Analysis
  • Industry Trends
  • Key Highlights
  • Epidemiology
  • Reimbursement Scenario
  • Regulatory Scenario
  • Product Launch and Approvals
  • Acquisition and Collaboration Scenario

4. Global Bacillus Coagulans Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Bacillus Coagulans Market, By Application, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Non-Dairy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Dairy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Cereal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Infant Nutrition
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Bacillus Coagulans Market, By End-Users, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cosmeceutical Manufacturers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Food and Beverages
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Nutraceutical
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Bacillus Coagulans Market, By Region, 2020 - 2032, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Users, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Users, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Users, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Users, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End-Users, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East & Africa

8. Competitive Landscape

  • Company Profiles
    • Sanzyme
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Unique Biotech Limited (UBL)
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Zytex
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bioflex
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Fengchen Group Co., Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • RAJVI Enterprise
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Vakya life sciences
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sabinsa Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Ganeden
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • UAS Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Mitsubishi Chemical Foods Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Mystical Biotech Pvt. Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Aumgene Biosciences
    • Unique Biotech Ltd.
    • Nebraska Culture

9. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact